BeOne Medicines AG annual operating income for fiscal 2025 was $447 million, compared with -$568 million in fiscal 2024. All figures are reported results from public filings — no estimates or projections.
| Operating Income (annual) | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Operating Income (EBIT) | $447M | ($568M) | ($1.2B) | ($1.8B) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Operating Income (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Operating Income (EBIT) | $325M | $250M | $185M | $163M | $88M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More 6160 metrics: Revenue · Gross Profit · Net Income · EPS · Free Cash Flow
All 6160 financial statements → Interactive 6160 charts →
About TickerBase · Data methodology & sources · Privacy · Terms